1082278--4/9/2009--ENVIRONMENTAL_SOLUTIONS_WORLDWIDE_INC

related topics
{product, candidate, development}
{stock, price, share}
{customer, product, revenue}
{product, liability, claim}
{product, market, service}
{financial, litigation, operation}
{control, financial, internal}
{personnel, key, retain}
IF CASH FLOWS FROM OPERATIONS ARE NOT SUFFICIENT AND IF ESW IS UNABLE TO OBTAIN ADDITIONAL FUNDING THEN, ESW MAY HAVE TO SIGNIFICANTLY CURTAIL THE SCOPE OF ITS OPERATIONS AND ALTER ITS BUSINESS MODEL. ESW HAS INCURRED LOSSES IN THE PAST AND EXPECTS TO INCUR LOSSES IN THE FUTURE SHOULD ITS BUSINESS PLAN NOT BE EFFECTIVE. THE PRICE OF ESW'S SHARES MAY BE ADVERSELY AFFECTED BY THE PUBLIC SALE OF A SIGNIFICANT NUMBER OF THE SHARES ELIGIBLE FOR FUTURE SALE. THE PRICE OF ESW'S COMMON STOCK HAS BEEN HIGHLY VOLATILE. ESW'S COMMON STOCK IS CURRENTLY TRADED ON THE OVER-THE-COUNTER-BULLETIN-BOARD AND THE FRANKFURT EXCHANGE AND AN INVESTOR'S ABILITY TO TRADE ESW'S COMMON STOCK MAY BE LIMITED BY TRADING VOLUME. WHICH WOULD RESULT IN SUBSTANTIAL DILUTION. SEVERAL OF ESW'S SHAREHOLDERS OWN A SIGNIFICANT AMOUNT OF ESW'S OUTSTANDING SHARES AND COLLECTIVELY MAY BE ABLE TO DECIDE CERTAIN CORPORATE ACTION. ESW'S RESULTS MAY FLUCTUATE DUE TO CERTAIN REGULATORY, MARKETING AND COMPETITIVE FACTORS OVER WHICH ESW HAS LITTLE OR NO CONTROL. ESW IS CURRENTLY DEPENDENT ON A FEW MAJOR CUSTOMERS FOR A SIGNIFICANT PORTION OF ITS REVENUES. ESW DOES NOT HAVE A LONG HISTORY OF SELLING AND MARKETING ITS PRODUCTS. ESW DEPENDS UPON THE MARKETABILITY OF ITS CORE PRODUCTS. ESW MAY NOT BE ABLE OBTAIN DIRECT OR INDIRECT REGULATORY CERTIFICATION OR VERIFICATION APPROVALS WITH RESPECT TO ITS PRODUCTS. ESW FACES CONSTANT CHANGES IN GOVERNMENTAL STANDARDS BY WHICH ITS PRODUCTS ARE EVALUATED. ESW DOES NOT HAVE A LONG HISTORY OF MANUFACTURING ITS PRODUCTS AND DOES NOT HAVE A LONG HISTORY OF MANUFACTURING ITS PRODUCTS IN COMMERCIAL QUANTITIES. ESW FACES INTENSE COMPETITION AND RAPID TECHNOLOGICAL ADVANCES FROM COMPETITORS. ESW CLAIMS CERTAIN PROPRIETARY RIGHTS IN CONNECTION WITH THE DESIGN AND MANUFACTURE OF ITS PRODUCTS. ATTRACTION AND RETENTION OF KEY PERSONNEL. ESW IS DEPENDANT UPON KEY SUPPLIERS FOR CERTAIN PRECIOUS METALS WHICH ARE ONE OF THE NECESSARY COMPONENTS OF ITS PRODUCTS. ESW DOES NOT HAVE A SIGNIFICANT LEVEL OF PRODUCT LIABILITY INSURANCE DUE TO ITS HIGH COST. JOINT VENTURES AND/OR RELATIONSHIPS ENTERED INTO OR SOUGHT BY ESW FOR DEVELOPMENT AND SALE OF ITS PRODUCTS.

Full 10-K form ▸

related documents
1082278--4/6/2010--ENVIRONMENTAL_SOLUTIONS_WORLDWIDE_INC
1314102--9/25/2009--pSivida_Corp.
849043--3/15/2007--NEUROGEN_CORP
1159036--3/14/2008--HALOZYME_THERAPEUTICS_INC
911216--9/28/2009--PALATIN_TECHNOLOGIES_INC
352747--3/16/2006--UNIGENE_LABORATORIES_INC
1114872--3/29/2006--MILLENNIUM_CELL_INC
755806--3/1/2006--NEORX_CORP
1360214--3/31/2010--TRANSDEL_PHARMACEUTICALS_INC
1054274--4/2/2007--HEPALIFE_TECHNOLOGIES_INC
880431--3/14/2007--GENAERA_CORP
873303--3/16/2010--AVI_BIOPHARMA_INC
727510--3/12/2010--ENZON_PHARMACEUTICALS_INC
1066833--3/30/2007--DOV_PHARMACEUTICAL_INC
1364326--1/5/2010--Pure_Pharmaceuticals_CORP
704562--7/14/2006--PEREGRINE_PHARMACEUTICALS_INC
1099215--7/31/2007--PROTALEX_INC
946644--3/17/2008--HEMISPHERX_BIOPHARMA_INC
873303--3/10/2009--AVI_BIOPHARMA_INC
1360214--3/26/2009--TRANSDEL_PHARMACEUTICALS_INC
1171012--3/12/2010--Uni-Pixel
1171012--3/6/2009--Uni-Pixel
1054274--3/31/2008--HEPALIFE_TECHNOLOGIES_INC
1396238--3/31/2010--IRIS_BIOTECHNOLOGIES_INC
1396238--3/31/2009--IRIS_BIOTECHNOLOGIES_INC
743884--3/17/2008--MACROCHEM_CORP
1013238--3/30/2007--ARADIGM_CORP
849043--3/14/2006--NEUROGEN_CORP
1314052--1/13/2009--ANAVEX_LIFE_SCIENCES_CORP.
357097--4/15/2009--ISOLAGEN_INC